Rethink Impact is a venture capital firm investing in female leaders using technology to solve the world’s biggest problems.
Business Model: B2B
Revenue: $0
Employees: 0-0
Address: --
City: New York
State: NY
Zip: --
Country: US
Rethink Impact is the largest, US-based impact venture capital firm with a gender lens that invests in female leaders using technology to solve the world’s biggest problems. We believe that the next generation of extraordinary companies (in health, environmental sustainability, education, and economic empowerment) will find success through their relentless pursuit of mission, for the benefit of all communities. We seek mission-driven founders and teams leveraging breakthrough innovations in technology for the benefit of people and planet. Our primary focus is on companies with female CEOs, or in some cases, women in C-level roles (e.g. CTO, COO, CRO, or CFO). We write $2M-$10M checks to lead or co-invest in Late Seed–Series C rounds. We look for companies with $500K-$15M in annual recurring revenue that are on a path to grow to $50M-$100M in the next five years (although, we will invest in later-stage deals where we believe we can have a significant impact and where the company is a fit for our mission more broadly). We have a bias towards capital-efficient, software solutions and marketplaces solving critical problems for businesses (B2B and B2B2C) and, ultimately, the communities they serve. We are actively sourcing investments that are making new digital health and education innovations broadly accessible to improve outcomes and reduce costs, providing tools for individuals and families to move up the economic ladder, and speeding the transition to a more sustainable and resource-efficient economy. We work to actively support our portfolio companies, helping them with everything from their next round of financing to leveraging their mission as a competitive advantage in hiring, growth, and brand building.
Contact Phone:
Contact Email:
Announced Date | Company | Transaction | Money Raised |
---|---|---|---|
10/2020 | KETOS | Series B | 0 |
2/2019 | KETOS | Series A | 0 |
11/2020 | Aclima | Series B | 0 |
7/2021 | Morty | Series B | 0 |
1/2016 | Purpose Global | Venture Round | - |
6/2018 | Winnie | Seed Round | 4M |
6/2018 | Aclima | Series A | 24M |
7/2018 | Guild Education | Series C | 40M |
7/2020 | Evidation Health | Series D | 45M |
6/2021 | Sempre Health | Series B | 15M |
4/2022 | Eleanor Health | Series C | 0 |
12/2018 | Savonix | Series A | 9.6M |
7/2020 | Icon Savings Plan | Seed | 3.2M |
8/2017 | Werk | Seed Round | 2.8M |
6/2017 | Savonix | Series A | 5.1M |
12/2014 | Change.org | Series C | 0 |
9/2021 | Spring Health | Series C | 0 |
10/2017 | Angaza | Series B | 10.5M |
11/2020 | Spring Health | Series B | 0 |
7/2016 | EVERFI | Series C | 0 |
5/2022 | Regrow Ag | Series B | 0 |
1/2020 | Realm | Series A | - |
9/2017 | KETOS | Seed Round | 2.6M |
6/2017 | NextSeed | Series A | 0 |
6/2015 | Classy | Series B | 0 |
6/2021 | Wellthy | Series B | 0 |
6/2020 | CareAcademy | Series A | 0 |
3/2019 | Ellevest | Series A | 0 |
6/2019 | Neurotrack | Series C | 21M |
12/2021 | Full Harvest | Series B | 0 |
4/2019 | Binti | Series A | - |
8/2021 | Binti | Series B | 45M |
10/2020 | Angaza | Series B | 0 |
3/2021 | Candidly | Series A | 0 |
7/2018 | Spring Health | Seed Round | 0 |
2/2018 | Univfy | Series A | 6M |
10/2020 | Full Harvest | Venture Round | - |
9/2021 | EveryDay Labs | Series A | 8M |
9/2017 | Ellevest | Series A | 0 |
10/2019 | Winnie | Series A | 9M |
9/2021 | Solv | Series C | 0 |
8/2022 | Incredible Health | Series B | 0 |
3/2018 | Neurotrack | Series B | 13.7M |
3/2019 | Candidly | Series A | 0 |
5/2020 | Binti | Venture Round | - |
8/2020 | Juntos | Venture Round | - |
1/2021 | Oncue | Series A | 10M |
8/2018 | Sempre Health | Series A | 8M |
5/2022 | Culina Health | Seed Round | 0 |
5/2022 | Culina Health | Seed Round | 0 |
5/2022 | Regrow Ag | Series B | 0 |
4/2022 | Eleanor Health | Series C | 0 |
12/2021 | Full Harvest | Series B | 0 |
9/2021 | Spring Health | Series C | 0 |
9/2021 | Solv | Series C | 0 |
9/2021 | EveryDay Labs | Series A | 0 |
7/2021 | Morty | Series B | 0 |
6/2021 | Wellthy | Series B | 0 |
6/2021 | Sempre Health | Series B | 0 |
Name | Price |
---|
Name | Size | Announced Date |
---|